Business
Press Release Jun 03 2021
Cadila Healthcare Limited has informed the Exchange regarding a press release dated Jun 03, 2021, titled "Zydus Cadila receives tentative approval from USFDA for Osimertinib Tablets".
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Cadila Healthcare Limited has informed the Exchange regarding a press release dated Jun 03, 2021, titled \"Zydus Cadila receives tentative approval from USFDA for Osimertinib Tablets\". View Attachment","length":336,"tagName":"div"}]